Skip to content

Melilax

by Aboca S.P.A. Società Agricola Italy EUDAMED

Ref 08032472031369

EMDN G05

Regulatory status

as of 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR NumberCSQ0009231226 Date30 Sep 2026IssuedStatusActive expires 26 Mar 2028

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Not covered

European Union — CE/MDR Active

Certificates

2 certificates · EUDAMED

EUDAMED certificates (2)
  • CSQ0009231226 Supplemented

    Quality management system EU MDR

    Issued
    30 Sep 2026
    Expires
    26 Mar 2028
    Reason
    Add device or group
  • CVD005626 Issued

    Technical documentation EU MDR

    Issued
    25 Feb 2026
    Expires
    26 Mar 2028

Specification

EUDAMED · synced 24 Oct 2026

Device Name
Melilax microclismi
Model / Reference
08032472031369
Primary DI / UDI-DI
08032472031369
Basic UDI-DI
8032472MEXax1ZW
EMDN Code
G05 Topical anorectal administered gastro-intestinal system devices
Device Class
Class III
Market of Registration
Spain

Manufacturer details

EUDAMED SRN
IT-MF-000029499

Properties & raw data

Show properties, registry sources and raw records
Other properties (13)
  • Sterile: No
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No

Sources (1)

  • EUDAMED 37772141-5950-4f50-a637-9b5774bbb33a 61 fields · synced 24 Oct 2026